US equities
|
MU
$1,043.64
▼-4.08%
NVDA
$232.09
▼-2.26%
SNDK
$1,606.62
▼-5.07%
AMD
$623.71
▼-3.43%
INTC
$106.96
▼-5.45%
SPCX
$161.92
▼-3.39%
PLTR
$197.79
▲+1.89%
META
$715.64
▼-0.79%
MU
$1,043.64
▼-4.08%
NVDA
$232.09
▼-2.26%
SNDK
$1,606.62
▼-5.07%
AMD
$623.71
▼-3.43%
INTC
$106.96
▼-5.45%
SPCX
$161.92
▼-3.39%
PLTR
$197.79
▲+1.89%
META
$715.64
▼-0.79%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Latest News about Jeffrey Murray
Recent news which mentions Jeffrey Murray
Virpax Completes FDA Required Preclinical Toxicology Studies For Its Licensed Molecular Envelope Technology
February 13, 2023
Tickers
VRPX
Tags
Jeffrey Murray
Benzinga
Markets
From
Benzinga